Improving outcomes with continuous glucose monitoring compared to blood glucose monitoring in adults with inadequately controlled, insulin-treated type 2 diabetes: a 12-month randomised trial

Nanna Lind; Merete Bechmann Christensen; Dorte Lindqvist Hansen; Kirsten Nørgaard

doi:10.1089/dia.2024.2525.abstracts

Improving outcomes with continuous glucose monitoring compared to blood glucose monitoring in adults with inadequately controlled, insulin-treated type 2 diabetes: a 12-month randomised trial

Nanna Lind^*, Merete Bechmann Christensen, Dorte Lindqvist Hansen, Kirsten Nørgaard

^*Corresponding author for this work

Steno Diabetes Center Copenhagen

Original language	English
Article number	O078 / #675
Journal	Diabetes Technology & Therapeutics
Volume	26
Issue number	S2
Pages (from-to)	A80
ISSN	1520-9156
DOIs	https://doi.org/10.1089/dia.2024.2525.abstracts
Publication status	Published - 5 Mar 2024
Event	ATTD 2024 - 17th International Conference on Advanced Technologies & Treatments for Diabetes - Florence, Italy Duration: 6 Mar 2024 → 9 Mar 2024 https://attd.kenes.com/

Conference

Conference	ATTD 2024 - 17th International Conference on Advanced Technologies & Treatments for Diabetes
Country/Territory	Italy
City	Florence
Period	06/03/2024 → 09/03/2024
Internet address	https://attd.kenes.com/

Access to Document

10.1089/dia.2024.2525.abstracts

Cite this

Lind, N., Christensen, M. B., Hansen, D. L., & Nørgaard, K. (2024). Improving outcomes with continuous glucose monitoring compared to blood glucose monitoring in adults with inadequately controlled, insulin-treated type 2 diabetes: a 12-month randomised trial. Diabetes Technology & Therapeutics, 26(S2), A80. Article O078 / #675. https://doi.org/10.1089/dia.2024.2525.abstracts

Improving outcomes with continuous glucose monitoring compared to blood glucose monitoring in adults with inadequately controlled, insulin-treated type 2 diabetes: a 12-month randomised trial. / Lind, Nanna ; Christensen, Merete Bechmann ; Hansen, Dorte Lindqvist et al.
In: Diabetes Technology & Therapeutics, Vol. 26, No. S2, O078 / #675, 05.03.2024, p. A80.

Research output: Contribution to journal › Conference abstract in journal › Research

Lind, N , Christensen, MB , Hansen, DL & Nørgaard, K 2024, 'Improving outcomes with continuous glucose monitoring compared to blood glucose monitoring in adults with inadequately controlled, insulin-treated type 2 diabetes: a 12-month randomised trial', Diabetes Technology & Therapeutics, vol. 26, no. S2, O078 / #675, pp. A80. https://doi.org/10.1089/dia.2024.2525.abstracts

@article{e2f517b058314aff8e856124a93e2646,

title = "Improving outcomes with continuous glucose monitoring compared to blood glucose monitoring in adults with inadequately controlled, insulin-treated type 2 diabetes: a 12-month randomised trial",

author = "Nanna Lind and Christensen, {Merete Bechmann} and Hansen, {Dorte Lindqvist} and Kirsten N{\o}rgaard",

year = "2024",

month = mar,

day = "5",

doi = "10.1089/dia.2024.2525.abstracts",

language = "English",

volume = "26",

pages = "A80",

journal = "Diabetes Technology & Therapeutics",

issn = "1520-9156",

publisher = "Mary Ann Liebert Inc.",

number = "S2",

note = "ATTD 2024 - 17th International Conference on Advanced Technologies & Treatments for Diabetes, ATTD 2024 ; Conference date: 06-03-2024 Through 09-03-2024",

url = "https://attd.kenes.com/",

}

TY - ABST

T1 - Improving outcomes with continuous glucose monitoring compared to blood glucose monitoring in adults with inadequately controlled, insulin-treated type 2 diabetes: a 12-month randomised trial

AU - Lind, Nanna

AU - Christensen, Merete Bechmann

AU - Hansen, Dorte Lindqvist

AU - Nørgaard, Kirsten

PY - 2024/3/5

Y1 - 2024/3/5

U2 - 10.1089/dia.2024.2525.abstracts

DO - 10.1089/dia.2024.2525.abstracts

M3 - Conference abstract in journal

SN - 1520-9156

VL - 26

SP - A80

JO - Diabetes Technology & Therapeutics

JF - Diabetes Technology & Therapeutics

IS - S2

M1 - O078 / #675

T2 - ATTD 2024 - 17th International Conference on Advanced Technologies & Treatments for Diabetes

Y2 - 6 March 2024 through 9 March 2024

ER -